How to Report Side Effects (FDA MedWatch)
Reporting medication side effects helps keep everyone safer. Learn how to use the FDA MedWatch system, what to report, and how your report contributes to drug safety monitoring.
Why Reporting Matters
Clinical trials that lead to drug approval typically involve a few thousand patients over a limited time period. This means that rare side effects, those occurring in fewer than 1 in 1,000 patients, may not be detected until the drug is used by millions of people in the real world. Post-marketing surveillance depends heavily on voluntary reports from patients and healthcare providers to identify these previously unknown risks.
Side effect reports have led to some of the most important drug safety actions in history. The withdrawal of rofecoxib (Vioxx) for cardiovascular risk, the addition of black box warnings to antidepressants regarding suicidality in young adults, and the discovery that fluoroquinolone antibiotics can cause tendon rupture were all driven by accumulating voluntary reports.
Every report contributes to a larger picture. A single report of an unusual side effect may not trigger action, but when the FDA sees a pattern of similar reports, it can investigate and take steps to protect public health.
What Is FDA MedWatch?
FDA MedWatch is the United States Food and Drug Administration's safety information and adverse event reporting program. It was established in 1993 to facilitate the reporting of serious adverse events, product quality problems, and medication errors associated with FDA-regulated products. MedWatch covers human drugs (prescription and OTC), biologics, medical devices, dietary supplements, and cosmetics.
The MedWatch system feeds reports into the FDA Adverse Event Reporting System (FAERS), a database containing millions of adverse event reports. Researchers, regulators, and pharmaceutical companies use FAERS to identify safety signals and monitor drug risk.
What to Report
You should report any side effect that is serious, unexpected, or concerning. The FDA defines a serious adverse event as one that results in death, is life-threatening, requires hospitalization or prolongs an existing hospitalization, causes persistent or significant disability, results in a birth defect, or requires medical intervention to prevent one of the above outcomes.
However, you can and should report any adverse event you believe is related to a medication, even if it does not meet the definition of "serious." Reports of non-serious but frequent side effects help the FDA understand the full safety profile of a drug.
You should also report medication errors (receiving the wrong drug or dose), product quality problems (unusual appearance, contamination, packaging defects), and therapeutic failures (the drug did not work as expected when used correctly).
How to File a Report
Online (Recommended)
The easiest way to report is through the FDA MedWatch online form at www.fda.gov/medwatch. The online form takes approximately 10 to 15 minutes to complete. You will need information about the patient (age, sex, weight), the suspected medication (name, dose, frequency, manufacturer), the adverse event (description, date of onset, outcome), and any other medications the patient was taking.
By Phone
You can call FDA MedWatch at 1-800-FDA-1088 (1-800-332-1088) Monday through Friday, 8 AM to 4:30 PM Eastern Time.
By Mail
Download FDA Form 3500 from the MedWatch website, complete it, and mail it to the address provided on the form.
Through Your Healthcare Provider
Healthcare providers are required to report certain serious adverse events (especially for vaccines through the VAERS system). Your doctor, pharmacist, or nurse can file a report on your behalf and may have additional clinical information to include.
What Happens After You Report
Once submitted, your report enters the FAERS database. FDA safety evaluators review incoming reports and look for signals, patterns of reports suggesting a potential safety concern. If a signal is detected, the FDA may request the manufacturer to conduct additional studies, update the drug's labeling (adding new warnings or contraindications), issue a Drug Safety Communication to alert the public, restrict the drug's use or add a Risk Evaluation and Mitigation Strategy (REMS), or in extreme cases, withdraw the drug from the market.
Your individual report is confidential. The FDA protects the identity of reporters and patients. You may receive a follow-up contact if the FDA needs additional information about your report.
Other Reporting Channels
Manufacturer reporting: You can also report side effects directly to the drug manufacturer. Each drug label includes a phone number for the manufacturer. Manufacturers are legally required to forward serious reports to the FDA.
International systems: Other countries have their own reporting systems. Canada uses the Canada Vigilance Program, the UK uses the Yellow Card Scheme (MHRA), and the European Union uses EudraVigilance. The World Health Organization (WHO) maintains the global VigiBase database that aggregates reports from over 130 countries.
Vaccine-specific reporting: Adverse events from vaccines should be reported to the Vaccine Adverse Event Reporting System (VAERS) at vaers.hhs.gov, which is jointly managed by the FDA and CDC.
Your participation in pharmacovigilancePharmacovigilance The science and activities relating to the detection, assessment, understanding, and prevention of adverse drug effects. Pharmacovigilance continues throughout a drug's entire market life and includes
This guide is for educational purposes only. It does not replace professional medical advice. Always consult your healthcare provider before making changes to your medication regimen.